North, Central & East London

We are delighted to be reopening our main office on Theobalds Road, central London as of 22 September. The building will be open one day a week (Thursdays), and we will continue to monitor the situation. Members and all visitors will need to complete and return a screening questionnaire before comin...

Considering the most recent developments regarding COVID-19, and current uncertainty surrounding mass gatherings in the UK, today RCPCH Senior Officers have made the difficult decision to cancel the new Member and Fellow Admission Ceremony which was due to take place on Thursday 19 March 2020 at Chu...

Dr John Criddle from the Evelina London Children’s Hospital describes the introduction of point of care diagnostics in the paediatric emergency department (PED) and its impact on patient flow.

The Mayor of London's Ultra Low Emission Zone has now come into force. RCPCH welcomes the move, but says we also need to see employers and schools encouraging and facilitating better use of public transport and active travel options.

The Regional Lead is the ambassador and advocate for each RCPCH region in the UK. Through an Area Officer, they represent members in Council and other meetings, and they liaise with specialty training bodies to help ensure the quality of training. The Regional Lead is in this post for three years, w...

Junk food advertising will be banned on the entire Transport for London (TfL) network from February under groundbreaking measures to help tackle child obesity, the Mayor of London confirmed today.

RCPCH supports the #AskAboutAsthma campaign as NHS in London ask sufferers to ‘take three small steps to improve lives’.

We congratulate the Mayor of London on his bold move and urge others to follow suit.

​​Your Area Officer who represents you at Council is Dr Indrani Banerjee. Find out more about useful contacts and activity in your RCPCH region.

Statistics published today by NHS Digital show that the proportion of children receiving the Measles, Mumps and Rubella (MMR) vaccine by age five has increased year on year since 2006-07. Coverage was 95.0% cent in 2016-17 compared with 94.8% for 2015-16, meeting the World Health Organisation (WHO) ...